Relay Therapeutics, Inc.

Contributing Author

Recent Articles by Relay Therapeutics, Inc.

2 hours	Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 RLAY GlobeNewswire
May-29	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June RLAY GlobeNewswire
May-08	Relay Therapeutics to Participate in Two Upcoming Investor Conferences RLAY GlobeNewswire
May-05	Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates RLAY GlobeNewswire